Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

GERAS Frailty Rehabilitation at Home During COVID-19

perjantai 4. maaliskuuta 2022 päivittänyt: Alexandra Papaioannou, McMaster University

GERAS Frailty Rehabilitation at Home: Virtual Bundled Care for Seniors Who Are Frail to Build Strength and Resilience During COVID-19

The coronavirus disease 2019 (COVID-19) pandemic is keeping people apart, which can take a toll on physical and mental health. Many healthcare professionals are concerned vulnerable seniors may become deconditioned, which substantially increases risk of health complications and need for hospitalization. To address the immediate impact of COVID-19 policies (i.e., physical distancing, reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors. The investigators' aim is to understand how to best build resilience among vulnerable seniors in the community through at-home rehabilitation services (socialization, exercise, nutrition, and medication support).

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Interventio / Hoito

Yksityiskohtainen kuvaus

During this unprecedented time of COVID-19, many healthcare professionals are concerned that vulnerable seniors who are housebound and isolated will become deconditioned resulting in functional losses in mental status, continence and ability to complete activities of daily living. Total inactivity in seniors can result in a 10-20% decrease in muscle strength per week (1 -3% per day). Loss of muscle strength may quickly convert a vulnerable older adult who was ambulatory into a bedridden state. This will affect the health of seniors and increase demand on healthcare systems. An innovative model to deliver frailty rehabilitation services remotely is urgently needed to: 1) increase access to specialized services 2) provide added supports for seniors discharged from the hospital who are in need of rehabilitation and 3) build resilience in seniors to prevent re-hospitalization or institutionalization. Therefore, to address the immediate impact of COVID-19 policies (i.e., physical distancing and reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors. This proof-of-concept, randomized control trial aims to understand how to best build resilience among vulnerable seniors through at-home rehabilitation services using socialization, exercise, nutrition, and medication support.

The short-term immediate goals for this RCT are to help vulnerable seniors who are isolated because of physical distancing measures to build strength and resilience throughout the COVID-19 pandemic. The major deliverables are 1) the adaptation of an in-person program to virtual delivery 2) the piloting of a care pathway with inter-disciplinary professionals that can be expanded to reach a larger number of individuals.

The long-term goal of the study is the seamless implementation of a new model for multimodal Frailty Rehabilitation that closes the care gap in rehabilitation for frail seniors in the immediate and foreseeable future.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

70

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

  • Kanada
    • Ontario
      • Hamilton, Ontario, Kanada, L8M1W9
        • McMaster University - Hamilton Health Sciences (St. Peter's Site)

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

65 vuotta ja vanhemmat (Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Community-dwelling adults aged ≥ 65 years of age;
  • Score between 4-6 (inclusive) on the clinical frailty scale;
  • Able to ambulate independently with or without a walking aid; OR with caregiver supervision at home;
  • Obtain clearance for exercise: For hospital referrals - average resting heart rate between 50-100 bpm and average blood pressure less than or equal to 160/90mmHg (as per Canadian Society for Exercise Physiology guidelines for exercise clearance); OR Self- referrals: Obtain exercise clearance from their family physician prior to the first intervention session.

Exclusion Criteria:

  • Unable to speak or understand English and has no caregiver for translation;
  • Significant cognitive impairment where they may have difficulty following two-step commands;
  • Receiving palliative/end of life care;
  • Unstable angina or unstable heart failure;
  • Travel plans that would result in missing greater than 20% of the trial's 12-week duration;
  • Currently attending a group exercise program.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Kaksinkertainen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Socialization
Participants randomized to the socialization arm will receive once-weekly phone calls from medical student volunteers for a total of 12-weeks (n=35). This program pairs health professional student volunteers with older adults in the community to provide social comfort while heightened physical distancing measures are in place during the current COVID-19 pandemic. Attendance and duration of the phone calls will be logged.
Käyttäytyminen: Socialization
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
Kokeellinen: Multi-Modal Frailty Rehabilitation
Multi-modal frailty rehabilitation will involve virtual care including 1x/week socialization, 2x/week exercise (small group physiotherapy live-streamed sessions), nutrition (virtual consult), and medication support (virtual pharmacist consult) all through a videoconferencing system.
Käyttäytyminen: Socialization
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
Käyttäytyminen: Virtual Group Exercise
Participants will receive twice-weekly (one hour per class) virtual exercise via small-group physiotherapy sessions for a total of 12 weeks. All exercise sessions will occur virtually via a videoconferencing system. The classes will focus on functional movements specifically designed for seniors with frailty and mobility challenges, and will include modifications for gait aids such as canes or walkers. Class sizes will be small to allow for tailoring of exercises based on challenging, safe, progressive, evidence-based exercises. In accordance with recent guidelines to achieve 3 hours/week for fall prevention practice in older adults, participants will also be provided with tailored supplemental home exercises developed by the study physiotherapist to gain an additional 1 hour of physical activity.
Yhdistelmätuote: Nutrition Consult and Protein Supplementation

Nutrition Consult: Participants will be scheduled for a one-on-one virtual nutrition consult. During the consultation, study staff will assess the nutritional status of the participant and will provide them with counselling and coaching to improve their nutrition.

Protein Supplementation: Oral nutrition supplements commercially available from Nestle will be provided unless contraindicated. The oral nutrition supplement contains 360 calories and 14 grams of protein per serving. Participants are advised to take this with a meal or within 3 hours of exercise on activity days.

Käyttäytyminen: Medication Review
A study pharmacist will review the participant's medication list and will utilize Beers and/or START/STOPP criteria to provide recommendations to optimize/update their medications to the participant's healthcare provider. Study geriatricians will be listed as contacts on the primary care provider recommendations and available for consultation.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in Physical Function
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the 5x Sit-to-Stand (time to complete). Faster times to complete indicate better performance.
Baseline and 12 Weeks Post-Intervention
Change in Mental Health
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the Depression Anxiety Stress Scale (DASS-21). Higher scores indicate greater risk of depression, anxiety and stress [depression, anxiety, stress subscores range 0-21].
Baseline and 12 Weeks Post-Intervention

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in Sarcopenia
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls. Higher scores indicate greater level of sarcopenia [range 0-10].
Baseline and 12 Weeks Post-Intervention
Change in Frailty
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the Fit-Frailty Index. Higher scores indicate greater degree of frailty [range 0-1].
Baseline and 12 Weeks Post-Intervention
Change in Self-Efficacy
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABCs). Higher scores indicate greater balance confidence [range 0-100].
Baseline and 12 Weeks Post-Intervention
Self-Reported Change in Function, Health and Well-Being
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the interRAI Community Rehab Assessment - Self-Report
Baseline and 12 Weeks Post-Intervention
Clinician-Reported Change in Function, Health and Well-Being
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the interRAI Community Rehab Assessment - Clinician-Completed
Baseline and 12 Weeks Post-Intervention
Change in Fitness
Aikaikkuna: Weekly up to 12 weeks
Assessed by the Borg Rate of Perceived Exertion after exercise. Higher scores indicate greater level of exertion [range 6-20]. Also assessed using accelerometers (heart rate, sedentary time, physical activity time, energy expenditure).
Weekly up to 12 weeks
Program Satisfaction
Aikaikkuna: 12 Weeks Post-Intervention
Assessed using a program questionnaire in accordance with the Kirkpatrick 5-Level Evaluation Model. Scores will be on a 5-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree".
12 Weeks Post-Intervention
Change in Health-Related Quality of Life
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the EQ-5D-5L scale. Lower scores indicate better self-reported quality of life [range 0-100].
Baseline and 12 Weeks Post-Intervention
Change in Nutrition
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Assessed by the Subjective Global Assessment. Grades range from A-C where 'A' represents normal nutrition and 'C' represents severe malnourishment.
Baseline and 12 Weeks Post-Intervention
Change in Emergency Room Visits
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Number of emergency room visits will be recorded. Higher number of emergency room visits indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention
Change in Hospitalizations
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Number of hospitalizations will be recorded. Higher number of hospitalizations indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention
Change in Number of Calls to 911
Aikaikkuna: Baseline and 12 Weeks Post-Intervention
Number of calls to 911 will be recorded. Higher number of calls indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Feasibility Outcome #1 - Reach of intervention
Aikaikkuna: 12 Weeks Post-Intervention
Assessed by the number of individuals who participated. Target reach is 70 participants.
12 Weeks Post-Intervention
Feasibility Outcome #2 - Adoption of the Intervention
Aikaikkuna: 12 Weeks Post-Intervention
Assessed by number of referral sites. Target is 5 referral sites.
12 Weeks Post-Intervention
Feasibility Outcome #3 - Implementation of the Intervention
Aikaikkuna: 12 Weeks Post-Intervention
Assessed by the number of individuals who completed the intervention. Higher number of individuals completing the study indicates greater success in implementation.
12 Weeks Post-Intervention
Feasibility Outcome #4 - Maintenance of the Intervention
Aikaikkuna: 12 Weeks Post-Intervention
Assessed by the number of referral sites continuing with a second cohort. Greater number of referral sites continuing with a second cohort indicates greater maintenance.
12 Weeks Post-Intervention

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

McMaster University

Tutkijat

  • Päätutkija: Alexandra Papaioannou, MD, MSc, Scientific Director, GERAS Centre for Aging Research

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Keskiviikko 26. elokuuta 2020

Ensisijainen valmistuminen (Todellinen)

Maanantai 1. marraskuuta 2021

Opintojen valmistuminen (Todellinen)

Maanantai 1. marraskuuta 2021

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 31. heinäkuuta 2020

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Tiistai 4. elokuuta 2020

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 5. elokuuta 2020

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 7. maaliskuuta 2022

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 4. maaliskuuta 2022

Viimeksi vahvistettu

Tiistai 1. maaliskuuta 2022

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Avainsanat

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • 11408

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Kliiniset tutkimukset Hauras

Hae vastaavia kokeiluja

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

CROs by country

CROs in Kyrgyzstan

Ehdot

Harvinaiset sairaudet

Huumeiden interventiot

Ravintolisät

Sponsori / yhteistyökumppanit

Sijainnit

Tilaa